Advestra advises Novartis on its USD 3.7 billion notes

Novartis suc­cess­fully placed notes in the aggreg­ate prin­cip­al amount of USD 3.7 bil­lion in four tranches of USD 1 bil­lion 3.800% notes due 2029, USD 850 mil­lion 4.000% notes due 2031, USD 1.1 bil­lion 4.200% notes due 2034 and USD 750 mil­lion 4.700% notes due 2054. The notes were issued by Novartis Cap­it­al Cor­por­a­tion and guar­an­teed by Novartis AG.

Advestra acted as Swiss leg­al coun­sel to Novartis. The team included Annette Weber, Thomas Reut­ter and Mar­iëlle van Nim­we­gen (all Cap­it­al Mar­kets) as well as Céline Mar­tin (Tax).